# Naldebain for Pain Management After Knee Arthroplasty

> **NCT05266027** · PHASE4 · COMPLETED · sponsor: **Kaohsiung Medical University Chung-Ho Memorial Hospital** · enrollment: 80 (actual)

## Conditions studied

- Arthropathy of Knee Joint

## Interventions

- **DRUG:** Nalbuphine Sebacate (Naldebain)
- **DRUG:** Placebo medication

## Key facts

- **NCT ID:** NCT05266027
- **Lead sponsor:** Kaohsiung Medical University Chung-Ho Memorial Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-04-06
- **Primary completion:** 2022-11-28
- **Final completion:** 2022-11-28
- **Target enrollment:** 80 (ACTUAL)
- **Last updated:** 2023-03-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05266027

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05266027, "Naldebain for Pain Management After Knee Arthroplasty". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT05266027. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*